Table 4.
Clinical Prognosis and Expression Status of Nrf2, MRP1, NQO1, cmyc and p53
| Variables | Total | Survive | Dead | Mortality | P (bilateral) | |
|---|---|---|---|---|---|---|
| Nrf2 | low | 31 | 18 | 13 | 41.90% | 0.033 |
| high | 45 | 15 | 30 | 66.70% | ||
| MRP1 | low | 35 | 20 | 15 | 42.90% | 0.026 |
| high | 41 | 13 | 28 | 56.60% | ||
| NQO1 | low | 33 | 23 | 10 | 30.30% | 0 |
| high | 43 | 10 | 33 | 76.70% | ||
| cmyc | low | 30 | 16 | 14 | 46.70% | 0.159 |
| high | 46 | 17 | 29 | 56.60% | ||
| p53 | low | 24 | 16 | 8 | 33.30% | 0.005 |
| high | 52 | 17 | 35 | 56.60% | ||